Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition

Breast Cancer Research and Treatment

Volumn 75, Issue 1, 2002, Pages 73-85

  Dhanesuan, Nirada ^a   Sharp, Julie A ^b   Blick, Tony ^a   Price, John T ^a,b   Thompson, Erik W ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adhesion; Doxycycline; Proliferation SPARC; Tet On

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; DOXYCYCLINE; MATRIGEL; OSTEONECTIN; ANTIINFECTIVE AGENT;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL CYCLE S PHASE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRUCTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; MELANOMA CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; WESTERN BLOTTING; WOUND HEALING; BIOSYNTHESIS; BREAST TUMOR; CARCINOMA; CELL CULTURE; CELL DIVISION; CELL MOTION; FEMALE; PATHOLOGY;

ANTIBIOTICS, TETRACYCLINE; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; CELL MOVEMENT; DOXYCYCLINE; FEMALE; HUMAN; OSTEONECTIN; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR CELLS, CULTURED; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0036707707     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016536725958     Document Type: Article

References (50)

1. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC
2. Osteonectin, a bone-specific protein linking mineral to collagen
3. SPARC, a matricellular glycoprotein with important biological functions
4. SPARC, a matricellular protein: At the crossroads of cell-matrix
5. +2-dependent binding to the extracellular matrix
6. 2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells
7. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
8. Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone
9. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells
10. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000
11. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo
12. Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization
13. Involvement of SPARC in in vitro differentiation of skeletal myoblasts
14. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens
15. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation
16. Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen
17. SPARC/Osteonectin induces MMP-2-activation in human breast cancer cell lines
18. The epithelial to mesenchymal transition and metastatic progression in carcinoma
19. LacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis
20. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism
21. Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40
22. Transcriptional activation by tetracyclines in mammalian cells
23. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
24. Structure and expression of osteonectin mRNA in human tissue
25. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: Evidence for a role of EGFR in breast cancer growth and progression
26. Models for studying cellular invasion of basement membranes
27. Increased SPARC expression promotes U87 glioblastoma invasion in vitro
28. Distribution of SPARC in normal and neoplastic human tissue
29. Human platelets contain and secrete osteonectin, a major protein of mineralized bone
30. Expression of SPARC in normal and fibrotic livers
31. Immunological screening of SPARC/Osteonectin in nonmineralized tissues
32. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma
33. SPARC: A potential diagnostic marker of invasive meningiomas
34. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas
35. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: Implications for prognosis
36. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma
37. Differential expression of osteonectin/SPARC during human prostate cancer progression
38. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer
39. Comparative expression of the SPARC and stromelysin-3 genes in mammary tumours
40. Differentiation state and invasiveness of human breast cancer cell lines
41. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury
42. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro
43. The biology of sparc, a protein that modulates cell-matrix interactions
44. Terms of attachment: SPARC and tumorigenesis
45. Expression and structure of human SPARC transcripts: SPARC mRNA is expressed by human cells involved in extracellular matrix production and some of these cells show an unusual expression pattern
46. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1
47. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells
48. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury
49. Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells
50. Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content